Ni Fang 4
4 · Black Diamond Therapeutics, Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Ni Fang
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+100,000→ 100,000 totalExercise: $3.79Exp: 2032-02-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter.